Edition:
United States

Koninklijke Philips NV (PHG.AS)

PHG.AS on Amsterdam Stock Exchange

33.16EUR
17 Nov 2017
Change (% chg)

€-0.07 (-0.21%)
Prev Close
€33.23
Open
€33.31
Day's High
€33.44
Day's Low
€33.15
Volume
3,226,749
Avg. Vol
3,075,853
52-wk High
€36.12
52-wk Low
€26.40

Latest Key Developments (Source: Significant Developments)

Philips Lighting partners with Baidu in China‍​
Thursday, 16 Nov 2017 07:04am EST 

Nov 16 (Reuters) - PHILIPS LIGHTING NV ::PHILIPS LIGHTING PARTNERS WITH BAIDU TO BRING CONNECTED LIGHTING TO SMART HOMES IN CHINA‍​.  Full Article

Koninklijke Philips ‍reiterates its targets for 2017 - 2020 period​
Thursday, 2 Nov 2017 06:06am EDT 

Nov 2 (Reuters) - KONINKLIJKE PHILIPS NV ::‍REITERATES ITS TARGETS OF 4% - 6% COMPARABLE SALES GROWTH FOR 2017 - 2020 PERIOD​.‍REITERATES ITS TARGETS OF ADJUSTED EBITA MARGIN IMPROVEMENT OF 100 BASIS POINTS ON AVERAGE ANNUALLY FOR 2017 - 2020 PERIOD​.‍EXPECTS GENERATE APPROXIMATELY EUR 1 BILLION - EUR 1.5 BILLION OF FREE CASH FLOW ANNUALLY ​.‍EXPECTS IMPROVEMENT OF RETURN ON INVESTED CAPITAL (ROIC) TO MID-TO-HIGH TEENS BY 2020​.  Full Article

Koninklijke Philips collaborates with Thanh Vu Medic General Hospital in Vietnam‍​
Wednesday, 1 Nov 2017 06:29am EDT 

Nov 1 (Reuters) - KONINKLIJKE PHILIPS NV ::COLLABORATES WITH THANH VU MEDIC GENERAL HOSPITAL IN VIETNAM‍​.CONTRACT WILL LAST FROM 2018 TO 2020‍​.COLLABORATION TO PROVIDE MEDICAL EQUIPMENT AND TRAINING PROGRAMS TO THE HOSPITAL.  Full Article

Koninklijke Philips starts share repurchase program for up to 150 million euros
Monday, 30 Oct 2017 03:08am EDT 

Oct 30 (Reuters) - KONINKLIJKE PHILIPS NV ::INITIATES SHARE REPURCHASE PROGRAM FOR AN AMOUNT OF UP TO EUR 150 MILLION.‍SHARE REPURCHASE PROGRAM STARTS ON OCT 30 AND IS EXPECTED TO BE COMPLETED BEFORE DEC 31.  Full Article

Koninklijke Philips Q3 sales rise to 4.1 billion euros‍​
Monday, 23 Oct 2017 01:20am EDT 

Oct 23 (Reuters) - KONINKLIJKE PHILIPS NV ::Q3 SALES INCREASED TO EUR 4.1 BILLION, WITH COMPARABLE SALES GROWTH OF 4%‍​.Q3 REUTERS POLL: EUR 4.26 BILLION; EBITA EUR 437 MILLION; NET INCOME EUR 298 MILLION.COMPARABLE ORDER INTAKE INCREASED 5% COMPARED TO Q3 2016‍​.Q3 ADJUSTED EBITA MARGIN IMPROVED 12.8% OF SALES, COMPARED TO 11.4% OF SALES IN Q3 2016‍​.Q3 EBIT AMOUNTED TO EUR 299 MILLION VERSUS EUR 381 MILLION IN Q3 2016.Q3 NET INCOME EUR ‍​423 MILLION VERSUS EUR 383 MILLION YEAR AGO.OUTLOOK FOR 2017 REMAINS UNCHANGED.ON TRACK TO DELIVER 4 TO 6 PERCENT COMPARABLE SALES GROWTH AND IMPROVEMENT OF ADJUSTED EBITDA MARGIN OF AROUND 100 BASIS POINTS THIS YEAR‍​.  Full Article

Philips Lighting Q3 adjusted EBITDA up at 176 million euros
Thursday, 19 Oct 2017 01:07am EDT 

Oct 19 (Reuters) - PHILIPS LIGHTING NV ::Q3 ADJUSTED EBITA EUR ‍​176 MILLION VERSUS EUR 176 MILLION IN REUTERS POLL.REUTERS POLLS:Q3 NET IMCOME EUR 87.4 MILLION; Q3 SALES EUR 1.73 BILLION.‍Q3 SALES OF EUR 1,684 MILLION, WITH AN INCREASE IN COMPARABLE SALES OF 1.3%​.Q3 NET INCOME EUR 110‍​ MILLION VERSUS EUR 51 MILLION YEAR AGO.‍ON TRACK TO IMPROVE OUR ADJUSTED EBITA MARGIN BY 50-100 BASIS POINTS FOR FULL YEAR​.‍ ADJUSTED EBITA MARGIN GUIDANCE EXCLUDING A EUR 15 MILLION REAL ESTATE GAIN IN Q2​.‍EXPECT A STRONG FREE CASH FLOW IN Q4 BASED ON A SUBSTANTIAL REDUCTION IN INVENTORIES​.  Full Article

Philips receives FDA 510(k) clearance for 'small parts' ultrasound imaging solution
Friday, 13 Oct 2017 10:00am EDT 

Oct 13 (Reuters) - KONINKLIJKE PHILIPS NV ::PHILIPS RECEIVES U.S. FDA 510(K) CLEARANCE TO MARKET ITS SOLUTION FOR 'SMALL PARTS' ULTRASOUND IMAGING.  Full Article

Philips' subsidiary Philips North America LLC reaches agreement with U.S. DoJ, representing FDA
Wednesday, 11 Oct 2017 01:24am EDT 

Oct 11 (Reuters) - KONINKLIJKE PHILIPS NV ::PHILIPS REACHES AGREEMENT WITH THE U.S. GOVERNMENT ON A CONSENT DECREE FOCUSING ON THE COMPANY’S DEFIBRILLATOR MANUFACTURING IN THE U.S..ITS SUBSIDIARY PHILIPS NORTH AMERICA LLC REACHED AGREEMENT ON CONSENT DECREE WITH U.S. DOJ, REPRESENTING FDA‍​.‍ANTICIPATES AN EBITA IMPACT OF APPROXIMATELY EUR 20 MILLION IN Q4 OF 2017 AND APPROXIMATELY EUR 60 MILLION IN 2018​.AGREEMENT ON CONSENT DECREE RELATED TO COMPLIANCE WITH CURRENT GOOD MANUFACTURING PRACTICE REQUIREMENTS ARISING FROM PAST INSPECTIONS IN AND BEFORE 2015.DECREE WILL BECOME EFFECTIVE ONCE IT IS APPROVED BY THE U.S. DISTRICT COURT FOR THE DISTRICT OF MASSACHUSETTS..INSPECTIONS IN AND BEFORE 2015 PRIMARILY ON PHILIPS’ ECR BUSINESS OPERATIONS IN ANDOVER (MASSACHUSETTS) AND BOTHELL (WASHINGTON).UNDER DECREE, PHILIPS WILL SUSPEND MANUFACTURE AND DISTRIBUTION OF EXTERNAL DEFIBRILLATORS MANUFACTURED AT THESE FACILITIES.SUSPENSION, SUBJECT TO CERTAIN EXCEPTIONS, UNTIL FDA CERTIFIES FACILITIES’ COMPLIANCE WITH QUALITY SYSTEM REGULATION.IMPACTS ON EDBITDA RELATE TO SUSPENSION OF PRODUCTION, PROFIT DISGORGEMENT PAYMENTS AND INCREMENTAL COSTS TO PREPARE FOR AND HANDLE THE REGULATORY INSPECTIONS.AMOUNTS WILL NOT IMPACT ADJUSTED EBITA IN 2017 AND 2018, RESPECTIVELY.COMBINED SALES OF EXTERNAL DEFIBRILLATOR PRODUCT LINES AFFECTED BY TERMS OF DECREE WAS ABOUT EUR 35 MILLION PER QUARTER IN 2016.  Full Article

Philips and Indonesian Siloam Hospitals sign multi-year partnership agreement
Thursday, 5 Oct 2017 03:07am EDT 

Oct 5 (Reuters) - KONINKLIJKE PHILIPS NV ::‍PHILIPS AND INDONESIAN SILOAM HOSPITALS SIGN MULTIYEAR PARTNERSHIP AGREEMENT​.‍PHILIPS TO PROVIDE 21 SILOAM HOSPITALS ACROSS INDONESIA WITH MAINTENANCE AND SERVICES FOR ALL PHILIPS HEALTH TECHNOLOGY​.  Full Article

Philips demonstrates efficacy of Stellarex .035" low-dose drug-coated balloon in clinical trial at two years
Thursday, 14 Sep 2017 03:34pm EDT 

Sept 14 (Reuters) - Koninklijke Philips Nv ::Efficacy of Philips' Stellarex .035" low-dose drug-coated balloon demonstrated in clinical trial at two years.Koninklijke Philips NV says ‍data shows Stellarex demonstrates higher efficacy and patency results, longer treatment durability compared to uncoated balloon​.Koninklijke Philips NV -‍ 2 year data from ILLUMENATE EURCT validates durable clinical performance of Stellarex low-dose drug-coated balloon​.  Full Article

Philips, Zoll Medical near settlement in defibrillator patent lawsuit

Philips and Zoll Medical Corp have disclosed that they are nearing a settlement in a long-running patent lawsuit that would avoid an appeal by Philips of a jury's August decision to award it only a fraction of the $217 million it sought at trial.